Malta - English - Medicines Authority

hospira uk limited - norepinephrine - concentrate for solution for infusion - norepinephrine 2 mg/ml - cardiac therapy

Malta - English - Medicines Authority

hospira uk limited - norepinephrine - concentrate for solution for infusion - norepinephrine 2 mg/ml - cardiac therapy

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 4mg/4ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 8mg/8ml concentrate for solution for infusion ampoules (aguettant ltd - noradrenaline acid tartrate - solution for infusion - 1mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base;   - solution for infusion - 0.06 mg/ml - active: noradrenaline acid tartrate monohydrate 0.12 mg/ml equivalent to 0.06mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base - solution for infusion - 0.08 mg/ml - active: noradrenaline acid tartrate monohydrate 0.159 g/l equivalent to 0.08 g/l noradrenaline base excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base;   - solution for infusion - 0.12 mg/ml - active: noradrenaline acid tartrate monohydrate 0.239 mg/ml equivalent to 0.12 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base;   - solution for infusion - 0.16 mg/ml - active: noradrenaline acid tartrate monohydrate 0.319 mg/ml equivalent to 0.16 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

New Zealand - English - Medsafe (Medicines Safety Authority)

biomed limited - noradrenaline acid tartrate monohydrate 0.199 mg/ml equivalent to 0.1 mg/ml noradrenaline base;   - solution for infusion - 0.1 mg/ml - active: noradrenaline acid tartrate monohydrate 0.199 mg/ml equivalent to 0.1 mg/ml noradrenaline base   excipient: glucose sodium metabisulfite water for injection - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions).

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - noradrenaline acid tartrate - concentrate for soln for inf - 1 mg/ml - adrenergic and dopaminergic agents